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Introduction
The epidemiology of juvenile idiopathic arthritis (JIA) is
known to be variable worldwide and the therapeutic
approach to JIA is not standardized. Moreover, the avail-
ability of the novel and costly biologic medications is not
uniform throughout the world, with possible significant
impact on disease prognosis.
Objectives
The EPOCA study is aimed to obtain information on the
frequency of JIA subtypes in different geographic areas,
the therapeutic approaches adopted, and the disease status
of children with JIA currently followed worldwide.
Methods
Participation in the study was proposed to the pediatric
rheumatology center of all countries belonging to the
Pediatric Rheumatology International Trials Organiza-
tion (PRINTO), and to several centers in the US and
Canada. Each centre was asked to enroll 100 consecutive
JIA patients or, if less than 100, all consecutive patients
seen within 6 months. Each patient received a retrospec-
tive and cross-sectional assessment. Parent- and child-
reported outcomes were recorded through the adminis-
tration of the Juvenile Arthritis Multidimensional
Assessment Report (JAMAR). Participating countries
were grouped into 6 geographic areas.
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Median onset age, yrs 4 6.3 6.6 5.9 7.5 5.7
Systemic arthritis, N (%) 202 (7.1) 165 (7.6) 143 (18) 174 (24) 16 (4.9) 11 (13.9)
Oligoarthritis, N (%) 1398 (49.1) 958 (44.1) 247 (31.1) 256 (35.3) 103 (31.8) 25 (31.6)
Enthesitis related arthritis, N (%) 253 (8.9) 248 (11.4) 74 (9.3) 92 (12.7) 35 (10.8) 3 (3.8)
Uveitis, N (%) 495 (17.4) 232 (10.7) 51 (6.4) 40 (5.5) 38 (11.7) 4 (5.1)
Median disease activity (JADAS10) 2 5 3.5 3.5 2 5
Inactive disease, N (%) 1070 (37.6) 454 (20.9) 268 (33.7) 237 (32.6) 114 (35.2) 13 (16.5)
Articular damage (JADI) > 0, N (%) 352 (12.4) 531 (24.5) 257 (32.3) 136 (18.7) 60 (18.5) 27 (34.2)
Treated with biologics, N (%) 1067 (37.5) 637 (29.3) 273 (34.3) 134 (18.5) 178 (54.9) 27 (34.2)
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Results
Currently, 6,940 patients from 41 countries have been
entered in the web database. Comparison of data from
the different geographic areas is presented in Table 1.
Conclusion
Patients seen in Western Europe have a younger age at
onset and a greater prevalence of uveitis. Systemic
arthritis is more common in Asian patients, whereas
enthesitis related arthritis is less frequent in African
patients. Children from Africa and Eastern Europe have
a higher level of disease activity and a lower frequency
of inactive disease, and African and Latin American
patients have a greater prevalence of articular damage.
Biologic medication are administered more frequently in
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